» Articles » PMID: 26702123

Comparison of the Effect of Daily Consumption of Probiotic Compared with Low-fat Conventional Yogurt on Weight Loss in Healthy Obese Women Following an Energy-restricted Diet: a Randomized Controlled Trial

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2015 Dec 25
PMID 26702123
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite evidence for the beneficial effects of probiotics and low-fat dairy products, to our knowledge, no study has compared the beneficial effect on weight loss of consuming a probiotic yogurt (PY) compared with a standard low-fat yogurt (LF) during a hypoenergetic program.

Objective: We compared the effect of the PY with LF yogurt consumption on body weight and cardiometabolic risk factors in women during a weight-loss program.

Design: Overweight and obese women [body mass index (in kg/m(2)): 27-40; age: 18-50 y) who usually consumed standard LFs were asked to consume either PY or LF every day with their main meals for 12 wk while following a weight-loss program.

Results: A total of 89 participants were randomly assigned to one of the 2 intervention groups. Baseline variables were not significantly different between groups. A statistically significant reduction in anthropometric measurements and significant improvements in cardiometabolic risk characteristics were observed over the 12 wk in both groups. However, no significant differences in weight loss and anthropometric measurements were seen between groups after the intervention. Compared with the LF group, the PY group had a greater (mean ± SD) decrease in total cholesterol (PY = -0.36 ± 0.10 mmol/L, LF = -0.31 ± 0.10 mmol/L; P = 0.024), low-density lipoprotein cholesterol (PY = -0.35 ± 0.10 mmol/L, LF = -0.31 ± 0.11 mmol/L; P = 0.018), homeostasis model assessment of insulin resistance (PY = -0.55 ± 0.32, LF = -0.42 ± 0.20; P = 0.002), 2-h postprandial glucose (PY = -0.61 ± 0.24 mmol/L, LF = -0.44 ± 0.19 mmol/L; P < 0.001), and fasting insulin concentration (PY = -1.76 ± 1.01 mU/mL, LF = -1.32 ± 0.62 mU/mL; P = 0.002), as secondary endpoints after the study. No significant differences were found for fasting plasma glucose, high-density lipoprotein cholesterol, or triglycerides within both groups after the 12 wk.

Conclusion: Consumption of PY compared with LF with main meals showed no significant effects on weight loss. However, it may have positive effects on lipid profiles and insulin sensitivity during a weight-loss program. This trial was registered at http://www.irct.ir/ as IRCT201402177754N8.

Citing Articles

subsp. CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice.

Jang H, Joung H, Chu J, Cho M, Kim Y, Kim K Nutrients. 2025; 16(24.

PMID: 39770882 PMC: 11677567. DOI: 10.3390/nu16244260.


Association of dietary live microbes and nondietary prebiotic/probiotic intake with metabolic syndrome in US adults: evidence from NHANES.

Wang Z, Zhang H, Shao Z Sci Rep. 2024; 14(1):32132.

PMID: 39738746 PMC: 11685591. DOI: 10.1038/s41598-024-83971-7.


Effects of probiotic supplementation with high-intensity interval training on cardiorespiratory endurance and metabolism in Middle-Aged Obese Women.

Chen Y, Wang H, Ogita F, Hung C, Kuo C, Wang J J Int Soc Sports Nutr. 2024; 21(1):2425609.

PMID: 39618097 PMC: 11613408. DOI: 10.1080/15502783.2024.2425609.


Gut microbiome: A revolution in type II diabetes mellitus.

Jeyaraman M, Mariappan T, Jeyaraman N, Muthu S, Ramasubramanian S, Santos G World J Diabetes. 2024; 15(9):1874-1888.

PMID: 39280189 PMC: 11372632. DOI: 10.4239/wjd.v15.i9.1874.


Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: A meta-analysis of randomized controlled trials.

Cao N, Zhao F, Kwok L, Wang H, Sun Z Curr Res Food Sci. 2024; 9:100810.

PMID: 39114432 PMC: 11305212. DOI: 10.1016/j.crfs.2024.100810.